<b><i>Background:</i></b> Cognitive impairment induced by cerebral infarction has become a devastating health problem. More efficient predictors are required to evaluate the potential cognitive decline after cerebral infarction in clinic. Serum uric acid (UA) and high-sensitivity C-reactive protein (hs-CRP) are two factors reported to correlate with cognitive impairment. However, the understanding on serum UA and hs-CRP with cognitive dysfunction remains unclear. <b><i>Methods:</i></b> Serum UA and hs-CRP were evaluated in patients with cerebral infarction (<i>n</i> = 197) using single factor analysis and multivariate logistic regression analysis. Clinical and pathological characteristics were analyzed by logistic regression, respectively, and the results demonstrated the correlation between the pathological characteristics and the cognitive impairment post cerebral infarction. Montreal Cognitive Assessment (MoCA) was used to evaluate the patients’ cognitive function, and patients with a MoCA score <26 were recognized as with cognitive impairment. <b><i>Results:</i></b> Clinical characteristics related to cognitive impairment, including age, gender, blood pressure, serum UA, and hs-CRP were collected and analyzed. Serum UA and hs-CRP were identified to be potential predictors for post-stroke cognitive dysfunction, with higher serum UA levels correlated with better cognitive function and higher hs-CRP levels correlated with worse cognitive impairment. <b><i>Conclusion:</i></b> Serum UA and hs-CRP are two predictors for cognitive impairment post cerebral infarction.
High Sensitivity C-reactive Protein may be used as a Marker for Cognitive Impairment in Obese Egyptian Middle Age Females